Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity – a randomized controlled trial
Caroline Schneider, View ORCID ProfileChristoph Ryffel, View ORCID ProfileManuela Rabaglio, Thomas M. Suter, Kristin L. Campbell, View ORCID ProfilePrisca Eser, Matthias Wilhelm
doi: https://doi.org/10.1101/2023.02.06.23285559
Caroline Schneider
aDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland
cGraduate School for Health Sciences, University of Bern, Bern, Switzerland
Christoph Ryffel
aDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland
Manuela Rabaglio
dDepartment of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland
Thomas M. Suter
aDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland
Kristin L. Campbell
eDepartment of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
Prisca Eser
aDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland
bMedical Division Rehabilitation & Sports Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
Matthias Wilhelm
aDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland
bMedical Division Rehabilitation & Sports Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
Data Availability
The data underlying this article will be shared upon reasonable request to the corresponding author.
Posted February 08, 2023.
Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity – a randomized controlled trial
Caroline Schneider, Christoph Ryffel, Manuela Rabaglio, Thomas M. Suter, Kristin L. Campbell, Prisca Eser, Matthias Wilhelm
medRxiv 2023.02.06.23285559; doi: https://doi.org/10.1101/2023.02.06.23285559
Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity – a randomized controlled trial
Caroline Schneider, Christoph Ryffel, Manuela Rabaglio, Thomas M. Suter, Kristin L. Campbell, Prisca Eser, Matthias Wilhelm
medRxiv 2023.02.06.23285559; doi: https://doi.org/10.1101/2023.02.06.23285559
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)